ArticleCureus2022

Protein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies (PCSK9mab) in Clinical Practice at Secondary Care - Real World Multicentre Experience.

Bilal Bashir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.